Kiora Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€0.69
Target price
31.12.25
€1.00
Performance (%)
-37.75%
End price
14.12.24
-
Summary
This prediction is currently being closed. The BUY prediction by BiotechBee for Kiora Pharmaceuticals Inc. is performing very badly with a performance of -37.75%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kiora Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -2.195% | 0.670% | 0.546% |
| iShares Nasdaq 100 | -2.629% | 2.992% | 34.108% |
| iShares Nikkei 225® | -2.021% | 3.141% | 53.424% |
| iShares S&P 500 | -1.670% | 2.405% | 23.220% |
According to BiotechBee what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kiora Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 1,0
In the thread Trading Kiora Pharmaceuticals Inc.
Buy beendet

